Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gene Therapies for Tumor Treatment market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gene Therapies for Tumor Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Gene Therapies for Tumor Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Amgen
Novartis
Shanghai Sunway
Sibiono
Kite Pharma
By Type:
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
By End-User:
Hospital
Clinic
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene Therapies for Tumor Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Gene Induced Immunotherapy from 2016 to 2027
-
1.3.2 USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Oncolytic Virotherapy from 2016 to 2027
-
1.3.3 USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Gene Transfer from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.3 USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gene Therapies for Tumor Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gene Therapies for Tumor Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Gene Induced Immunotherapy
-
3.4.2 Market Size and Growth Rate of Oncolytic Virotherapy
-
3.4.3 Market Size and Growth Rate of Gene Transfer
4 Segmentation of Gene Therapies for Tumor Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gene Therapies for Tumor Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gene Therapies for Tumor Treatment in Hospital
-
4.4.2 Market Size and Growth Rate of Gene Therapies for Tumor Treatment in Clinic
-
4.4.3 Market Size and Growth Rate of Gene Therapies for Tumor Treatment in Other
5 Market Analysis by Regions
-
5.1 USA Gene Therapies for Tumor Treatment Production Analysis by Regions
-
5.2 USA Gene Therapies for Tumor Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Gene Therapies for Tumor Treatment Landscape Analysis
-
6.1 West USA Gene Therapies for Tumor Treatment Landscape Analysis by Major Types
-
6.2 West USA Gene Therapies for Tumor Treatment Landscape Analysis by Major End-Users
7 South USA Gene Therapies for Tumor Treatment Landscape Analysis
-
7.1 South USA Gene Therapies for Tumor Treatment Landscape Analysis by Major Types
-
7.2 South USA Gene Therapies for Tumor Treatment Landscape Analysis by Major End-Users
8 Middle West USA Gene Therapies for Tumor Treatment Landscape Analysis
-
8.1 Middle West USA Gene Therapies for Tumor Treatment Landscape Analysis by Major Types
-
8.2 Middle West USA Gene Therapies for Tumor Treatment Landscape Analysis by Major End-Users
9 Northeast USA Gene Therapies for Tumor Treatment Landscape Analysis
-
9.1 Northeast USA Gene Therapies for Tumor Treatment Landscape Analysis by Major Types
-
9.2 Northeast USA Gene Therapies for Tumor Treatment Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Amgen
-
10.1.1 Amgen Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Novartis
-
10.2.1 Novartis Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Shanghai Sunway
-
10.3.1 Shanghai Sunway Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Sibiono
-
10.4.1 Sibiono Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Kite Pharma
-
10.5.1 Kite Pharma Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Gene Induced Immunotherapy from 2016 to 2027
-
Figure USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Oncolytic Virotherapy from 2016 to 2027
-
Figure USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Gene Transfer from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure USA Gene Therapies for Tumor Treatment Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gene Therapies for Tumor Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gene Therapies for Tumor Treatment
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gene Therapies for Tumor Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Gene Therapies for Tumor Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Gene Induced Immunotherapy
-
Figure Market Size and Growth Rate of Oncolytic Virotherapy
-
Figure Market Size and Growth Rate of Gene Transfer
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gene Therapies for Tumor Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gene Therapies for Tumor Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Other
-
Table USA Gene Therapies for Tumor Treatment Production by Regions
-
Table USA Gene Therapies for Tumor Treatment Production Share by Regions
-
Figure USA Gene Therapies for Tumor Treatment Production Share by Regions in 2016
-
Figure USA Gene Therapies for Tumor Treatment Production Share by Regions in 2021
-
Figure USA Gene Therapies for Tumor Treatment Production Share by Regions in 2027
-
Table USA Gene Therapies for Tumor Treatment Consumption by Regions
-
Table USA Gene Therapies for Tumor Treatment Consumption Share by Regions
-
Figure USA Gene Therapies for Tumor Treatment Consumption Share by Regions in 2016
-
Figure USA Gene Therapies for Tumor Treatment Consumption Share by Regions in 2021
-
Figure USA Gene Therapies for Tumor Treatment Consumption Share by Regions in 2027
-
Table West USA Gene Therapies for Tumor Treatment Consumption by Types from 2016 to 2027
-
Table West USA Gene Therapies for Tumor Treatment Consumption Share by Types from 2016 to 2027
-
Figure West USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2016
-
Figure West USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2021
-
Figure West USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2027
-
Table West USA Gene Therapies for Tumor Treatment Consumption by End-Users from 2016 to 2027
-
Table West USA Gene Therapies for Tumor Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2016
-
Figure West USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2021
-
Figure West USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2027
-
Table South USA Gene Therapies for Tumor Treatment Consumption by Types from 2016 to 2027
-
Table South USA Gene Therapies for Tumor Treatment Consumption Share by Types from 2016 to 2027
-
Figure South USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2016
-
Figure South USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2021
-
Figure South USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2027
-
Table South USA Gene Therapies for Tumor Treatment Consumption by End-Users from 2016 to 2027
-
Table South USA Gene Therapies for Tumor Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2016
-
Figure South USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2021
-
Figure South USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2027
-
Table Middle West USA Gene Therapies for Tumor Treatment Consumption by Types from 2016 to 2027
-
Table Middle West USA Gene Therapies for Tumor Treatment Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2016
-
Figure Middle West USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2021
-
Figure Middle West USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2027
-
Table Middle West USA Gene Therapies for Tumor Treatment Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Gene Therapies for Tumor Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2016
-
Figure Middle West USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2021
-
Figure Middle West USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2027
-
Table Northeast USA Gene Therapies for Tumor Treatment Consumption by Types from 2016 to 2027
-
Table Northeast USA Gene Therapies for Tumor Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2016
-
Figure Northeast USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2021
-
Figure Northeast USA Gene Therapies for Tumor Treatment Consumption Share by Types in 2027
-
Table Northeast USA Gene Therapies for Tumor Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Gene Therapies for Tumor Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2016
-
Figure Northeast USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2021
-
Figure Northeast USA Gene Therapies for Tumor Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Shanghai Sunway
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Sunway
-
Figure Sales and Growth Rate Analysis of Shanghai Sunway
-
Figure Revenue and Market Share Analysis of Shanghai Sunway
-
Table Product and Service Introduction of Shanghai Sunway
-
Table Company Profile and Development Status of Sibiono
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sibiono
-
Figure Sales and Growth Rate Analysis of Sibiono
-
Figure Revenue and Market Share Analysis of Sibiono
-
Table Product and Service Introduction of Sibiono
-
Table Company Profile and Development Status of Kite Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma
-
Figure Sales and Growth Rate Analysis of Kite Pharma
-
Figure Revenue and Market Share Analysis of Kite Pharma
-
Table Product and Service Introduction of Kite Pharma
-
